2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
6
Other hematologic neoplasm
5
Lymphoid
5
Thoracic
2
Classical hematology
2
Head & Neck
1
Endocrine
1
Conditions
Neuroendocrine Tumors
531
Multiple Endocrine Neoplasia Type 1
187
Pituitary Neoplasms
186
Thyroid Cancer, Papillary
178
Pheochromocytoma
152
Carcinoma, Neuroendocrine
140
Thyroid Neoplasms
130
Neoplasms
107
Carcinoid Tumor
99
Paraganglioma
98
Adrenocortical Carcinoma
92
Thyroid Carcinoma, Anaplastic
82
Pancreatic Neoplasms
69
Neoplasm Metastasis
67
Insulinoma
61
Adrenal Gland Neoplasms
61
Gastro-enteropancreatic neuroendocrine tumor
58
Carcinoma, Medullary
58
Adenocarcinoma, Follicular
58
Carcinoma, Non-Small-Cell Lung
57
Breast Neoplasms
56
Adenoma, Islet Cell
56
Lung Neoplasms
50
Sarcoma
49
Colorectal Neoplasms
49
Carcinoma, Renal Cell
49
Melanoma
47
Small Cell Lung Carcinoma
45
Prostatic Neoplasms
44
Head and Neck Neoplasms
43
Interventions
Ketorolac
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Emergencies
×
Endocrine
×
Clear all
NCT01471639
2025-08-15
Sprix
The Cleveland Clinic
Phase NA
Completed
37 enrolled
7 charts